Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2010
May 3, 2010
- Quality Improvement Intervention Significantly Reduces Medication Use Across a Large Neonatal Network
- Ipsen?s partner Roche announces that Taspoglutide meets its primary endpoint in a key phase III clinical trial
- PROLOR Biotech Reports New Preclinical Data Supporting the Enhanced Biological Activity Potential of Its Biobetter Pipeline
- Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
- Novel GI Safer Aspirin Significantly Reduces Ulcers Compared to Regular Aspirin
- Celator Pharmaceuticals Announces Positive Data From Phase 2 Study of CPX-351 in Acute Myeloid Leukemia
- Anthera Pharmaceuticals Announces Additional Data from FRANCIS Study
- Three Out of Four Patients Uncontrolled on Monotherapy Achieved Blood Pressure Goal with Azor According to New Study Results
- GI Dynamics' EndoBarrier Gastrointestinal Liner Demonstrates Improvements in Blood Sugar Control and Facilitates Weight Loss in People Living with Type 2 Diabetes
- Acucela to Present Update on ACU-4429 at the Annual Retina International Scientific & Medical Advisory Board Meeting
- Antibiotic Use and Environmental Exposure are Key Factors Affecting Antibiotic Resistant Escherichia coli (E. coli) Carriage in Children in Peru
- Raptor Pharmaceutical Announces Phase 2a NASH Study Meets Primary Endpoints: Results Released at Digestive Disease Week Conference
- WILEX AG: Final Phase II data of Mesupron confirm impressive increase in overall survival of patients with pancreatic cancer
- Arterial Remodeling Technologies ("ART") to Disclose New Data About its Bioresorbable Stent at the 9th Annual 'EBR Symposium 2010', May 6th
- Rib-X to Present at Ribosomes 2010 Conference
- Cholesterol Drugs May Help Improve Hip Replacement Outcomes
- MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
- San Francisco Has the Highest Rate of Liver Cancer in the U.S.
- Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
- Pivotal Phase 3 Data Demonstrated Investigational Compound Azilsartan Medoxomil Lowered Blood Pressure in Head-to-Head Comparator Trials
- New Efficacy Data Shows Cimzia (certolizumab pegol) Provides Long-Term Remission of Moderate to Severe Crohn's Disease Regardless of Prior Anti-TNF Exposure, According to Data Presented at DDW
May 4, 2010
- Pharmasset Announces Results of a 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection
- Icon to Present Clinical Data on Verisome Technology in Cystoid Macular Edema at the ARVO Annual Meeting
- Epeius Biotechnologies Reports Major Clinical Advances: Noteworthy Clinical Case Studies in Cancer Gene Therapy
- BSD Medical Reports Press Release Issued by The Lancet Oncology on Significant Sarcoma Study Using BSD-2000 Hyperthermia System
- ChemoCentryx Reports that Traficet-EN Maintains Remission in Crohn's Disease at the Digestive Disease Week (DDW) 2010 Conference
- XIFAXAN 550 mg (rifaximin) Demonstrated Acute and Sustained Relief of Non-Constipation Irritable Bowel Syndrome Symptoms; Data from Target 1&2 Presented at Digestive Disease Week (DDW)
- Data From Optimer's Second Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) Featured in Oral Presentation at Digestive Disease Week
- QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo IR in Patients with Post-Surgical Pain
May 5, 2010
- Data on VIVUS' Qnexa to be Presented at European Congress Focused on Cardiovascular Prevention and Rehabilitation
- Pearl Therapeutics' Bronchodilator Combination Therapeutic for COPD to Be Presented at the American Thoracic Society Annual Meeting
- ADVENTRX Announces 6-Month Stability Data Results for ANX-530
- CytRx's INNO-206 Rapidly Shrinks Human Tumors in an Animal Model of Multiple Myeloma
- FST-100 Reduces Infectious Adenoviral Titers and Improves Clinical Signs in Conjunctivitis Model
- Data Presented at DDW About Rebound Symptoms in Healed Erosive Esophagitis Patients After Completion of Treatment with DEXILANT(TM) (dexlansoprazole)
- BELLUS Health ends NC-503 diabetes development program following results
- Surfaxin LS Improves Pulmonary Function and Reduces Lung Inflammation in Established Model of Respiratory Distress Syndrome
- Nymox Announces Positive New Results in 6 Year Study of NX-1207 for Benign Prostatic Hyperplasia
- Positive Phase 2 study with oral anti-MRSA antibiotic
May 6, 2010
- Celldex Therapeutics Announces Presentation of Four Abstracts at ASCO 2010 Meeting
- Biovitrum (SE) - Swedish Orphan Biovitrum presents first positive Kiobrina® clinical phase II data
- PurGenesis announces significant milestones within its pharmaceutical program
- Anavex Reports Animal Study Results as Lead Alzheimer's Compound Approaches Phase 1 Clinical Trials
- Newron reports SERENA trial top-line results for ralfinamide
- Resolvyx Presents Data Demonstrating Potential for Resolvin Therapeutics to Treat Corneal and Retinal Eye Diseases at ARVO 2010 Meeting
- Quark Pharmaceuticals Development Partner Pfizer Presents inVivo Activity of PF-04523655 at ARVO
- Anti-Fibrotic Data from Amira Pharmaceuticals' LPA1 Receptor Antagonist Program Published in the British Journal of Pharmacology
- POZEN Reports PA65020 Significantly Reduces the Incidence of Upper GI Damage in Healthy Adults
- Argos Therapeutics Presents Transplantation Data for Soluble CD83 Demonstrating its Ability to Induce Immune Tolerance and Suppress Anti-donor Antibody Responses
- JAMA Editorial Discusses Role of Influenza and Pneumonia Vaccines in Reducing Risks of Heart Attack, Stroke
- Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
- TCA Cellular Presents Promising Adult Stem Cells Treatment in Heart Attack Victims at SCAI Conference
- Cytochroma announces positive Phase I results for CTAP201 Injection in hemodialysis patients
May 7, 2010
- Cytori Reports Stem & Regenerative Cells from Body Fat Produce Statistically Significant Improvement in Heart Function in Chronic Ischemia Trial
- Cytori Reports Stem & Regenerative Cells from Body Fat Improve Outcomes in Heart Attack Clinical Trial; Plans Underway for European Multicenter Pivotal Trial
- Data Comparing Nucynta (tapentadol) Tablets to Oxycodone Immediate Release Tablets Presented at 2010 American Pain Society Annual Meeting
- Cempra Announces Positive Results From its Phase 2 Clinical Trial of TAKSTA (Sodium Fusidate) in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
- VBL Therapeutics Announces Positive Preclinical Data for VB-201 against Psoriasis ? First in New Class of Orally Available Anti-Inflammatory Compounds
- Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
- The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
- Drug-Eluting Peripheral Stent Continues to Show Positive Data at Two Years
- Mild-Mannered Metabolic Helper Rushes to Fight Invading Viruses, Researchers Report
May 10, 2010
- Novo Nordisk partners with international scientific community for Victoza cardiovascular outcomes trial
- BioInvent and ThromboGenics Announce Positive Topline Results from Phase II VTE Prophylaxis Study with Anti-Factor VIII (TB-402)
- MediGene AG (DE) - MediGene publishes first, preliminary results obtained in a phase II clinical trial of EndoTAGTM-1 for the treatment of triple receptor-negative breast cancer
- Endometrial Stem Cells Could Repair Brain Cells Damaged By Parkinson's Disease
- QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
May 11, 2010
- Data from Clinical Trial Examining Lubiprostone for the Treatment of Opioid-induced Bowel Dysfunction Presented at Digestive Disease Week Conference
- Forest and Almirall to Present Data from Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease (COPD) and LAS100977 in Asthma
- Forest and Nycomed to Present Results from Six Roflumilast Posters
- to Present at the American Society of Gene & Cell Therapy Annual Meeting
- Alnylam Scientists and Collaborators Publish Research on Key Mechanism for Delivery of RNAi Therapeutics with Lipid Nanoparticles (LNPs)
- International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing
- Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
- NexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT Technology to Enhance the Bioavailability of rituximab When Administered Subcutaneously
- Poniard Pharmaceuticals Announces Results of Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer to Be Presented at the American Society of Clinical Oncology 2010 Annual Meeting
May 12, 2010
- Achillion Announces Positive Once-Daily Dosing Results With ACH-1625 to Treat Hepatitis C
- Allovectin-7 Achieves Median Survival of Nearly 19 Months in Phase 2 Melanoma Trial
- Regeneron Provides Initial Data on Two Antibody Product Candidates
- BrainStorm to Present at World Stem Cells and Regenerative Medicine Congress
- 6Th Colloque Médecine Et Recherche of the Fondation Ipsen in the Cancer Science Series: ?Stem Cells and Cancer?
- Zymes LLC, University of Windsor and National Research Council of Canada Collaborative Research Presented at the 2010 Experimental Biology Meeting in Anaheim, California
- Endocyte Officials to Present Results from Four Clinical Trials at ASCO Annual Meeting
- SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
May 13, 2010
- Study Shows Leading Breast Cancer Drug Abraxane Increases Survival Time For Advanced Pancreatic Cancer
- Data on the Anti-inflammatory Activity of Cempra Pharmaceutical's CEM-101 Will be Presented at the American Thoracic Society 2010 International Conference
- Tripos Releases Next Generation Molecular Modeling Suite, SYBYL-X 1.1
- Ardea Biosciences to Present Additional Data on Gout Program at the Annual European Congress of Rheumatology
May 14, 2010
- Far Fewer People Had Flu in Winter of 2009/2010 Than in Previous Years
- New trial results highlight benefit of Enbrel treatment for improving the symptoms of anxiety and depression in psoriasis patients with psoriatic arthritis
- Discovery Labs' Phase 2a Aerosurf Study Published in Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Prometheus Announces New Method for Real-Time Monitoring of Patients Treated With Biologic Therapy
- Key Clinical Data Regarding Jennerex's JX-594 to be Featured at American Society of Gene and Cell Therapy Meeting
- Novavax Announces Publication of a Preclinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
- New Large Study Results Confirm Safety Profile of Zostavax, Merck's Shingles Vaccine, in People Aged 60 or Older
- Merck and Cardiome Announce Phase III Study Results Comparing Investigational Compound Brinavess (Vernakalant) Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm
- PharmaGap Announces Results of NCI Test Program
- First Human Data on RegeneRx's Drug Candidate RGN-259 Published in Archives of Ophthalmology
May 17, 2010
- SciClone Announces Additional Topline Results for SCV-07
- Anti-Pseudomonas Activity of KaloBios'/sanofi pasteur's KB001 May Prevent Serious Lung Infections and Limit Damaging Inflammation
- ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
- Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
- Positive Pivotal Results on escitalopram in Japan - Lundbeck's Partner Mochida Plans to File escitalopram for Regulatory Approval in First Quarter 2011 at the Latest
- Tranzyme Pharma Presents Data Demonstrating that TZP-101 (Ulimorelin) Restores Bowel Function in Patients with Postoperative Ileus (POI) Regardless of the Extent of Opioid Use
- AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients Will be Released in Connection With the ASCO Meeting in Chicago, June 2010
- Active Biotech (SE) - Active Biotech's Prostate Cancer Project TASQ Featured in Molecular Cancer
- Actelion Pharmaceuticals Ltd (CH) - Actelion announces presentation of positive Phase II results with selexipag in patients with pulmonary arterial hypertension at the American Thoracic Society 2010 International Conference
- Xcellerex, Pfenex Inc. and Collaborators Complete Successful Test: Rapid Production of Swine Flu H1 Hemagglutinin
- FibroGen Reports Preclinical Data Showing that FG-3019 Reversed the Process of Fibrosis in the Lung
- REVEAL RegistryData May Advance Patient Care in Pulmonary Arterial Hypertension
- Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin (MP-376) Treatment in Cystic Fibrosis Patients
- iCo Therapeutics iCo-007 Phase I Clinical Trial Meets Primary Endpoint
- Argos Therapeutics Presents Phase 2a Data for Arcelis HIV Program Demonstrating Positive Impact on Viral Diversity and Viral Load
- ImmunoCellular Therapeutics and Torrey Pines Institute Identify Peptides Which Show Potential To Generate Cancer Stem Cell Specific Immune Responses
May 18, 2010
- Cerenis Reports Positive Results for Phase 1 Study of CER-001, an HDL mimetic, for the Treatment of Cardiovascular Disease
- Immutep announces oral presentation at ASCO Annual Meeting of IMP321 final results in Phase I/II chemoimmunotherapy trial
- Preglem Announces Positive Phase III Results For Esmya (TM) As An Effective Treatment For Uterine Fibroids
- WILEX AG: Redectane meets both endpoints specificity and sensitivity with superiority over CT in its pivotal Phase III trial
- New Study Shows Enjuvia Significantly Reduced 'Sleep Time' Awakenings Caused by Hot Flashes in Postmenopausal Women
- Chelsea Therapeutics Reports Data From Study 303 Confirming Safety and Robust Therapeutic Benefit of Long-Term Northera Treatment in Neurogenic Orthostatic Hypotension
- Generex Biotechnology Announces Publication Of Novel Immunotherapeutic Cancer Vaccine Results In Patients With Prostate Cancer
- Wilex German Biotech Meets FDA Phase 3 Endpoints for Renal Cancer Diagnosis
- AEterna Zentaris: Publication in the Journal of the National Cancer Institute Demonstrates Perifosine Single Agent Potential in Neuroblastoma Tumors
- Publication in the Journal of the National Cancer Institute Demonstrates KRX-0401 (Perifosine) Single-Agent Potential in Neuroblastoma Tumors
- Oncolytics Biotech Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
May 19, 2010
- Geron Announces Positive Data on Its Small Molecule Telomerase Activator in Model of Idiopathic Pulmonary Fibrosis
- Boehringer Ingelheim Announces New Data on Flibanserin in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder
- Data on VIVITROL to be Presented at Upcoming American Psychiatric Association Annual Meeting
- Lantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting
- Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment
- New Evidence Caffeine May Slow Alzheimer?s Disease and Other Dementias and Restore Cognitive Function
- Pharmaxis Announces Sustained Benefit In Cystic Fibrosis Following Long Term Bronchitol Treatment
- Oncolytic viruses mediating anti-tumor immunity in human cancer patients published by Oncos Therapeutics and University of Helsinki
- Vaxon Biotech successfully completes its Phase I/II trial of Vx-001 cancer vaccine, Phase III ready to start in NSCLC
- Data Suggest Denufosol May Hold Promise as an Early Intervention Treatment for Cystic Fibrosis
- Preoperative Statin Therapy Protects Elective Aneurysm Patients
May 20, 2010
- Santhera Pharmaceuticals Holding AG (CH) - Santhera's MICONOS Trial with Catena/Sovrima in Friedreich's Ataxia Misses Primary Endpoint
- Horizon Pharma, Inc. Presents Interim Results from a Pilot Clinical Study Evaluating LODOTRA in the Treatment of Severe Nocturnal Asthma
- Encouraging Data Presented on Oncophage Vaccine at International Conference on Brain Tumor Research and Therapy
- Lytix Biopharma as Update on Phase I Progress with Oncopore for Solid Tumours
- Cempra Pharmaceutical's CEM-101 Demonstrates Potent Anti-Inflammatory Activity, Compared to Other Macrolide Antibiotics, in an Inflammation Cell Model at the American Thoracic Society 2010 International Conference
- VIA Pharmaceuticals and MHI Announce Publication of VIA-2291 5-Lipoxygenase Inhibitor Clinical Study Data in Circulation: Cardiovascular Imaging
- UAB study examines hearing loss, Viagra use
- Phase III Study Showed First-Line Maintenance Use of Rituxan® Improved the Likelihood of People with Follicular Lymphoma Living without Their Disease Worsening
- New Data from Adrenoleukodystrophy (ALD) Pilot Study Presented at American Society of Gene and Cell Therapy Show Three-Year Disease Stabilization of Patients
- Jennerex Reports Positive Phase 1 Results for JX-594 Administered Intravenously
- Mount Sinai identifies first drug to demonstrate therapeutic effect in a type of autism
- NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
- Abbott to Present New Clinical Data on Current and Future Innovations in Interventional Cardiology at EuroPCR 2010
- New Study Data Presented on Sunridge International's PNT Treatment
- Clinical Data Demonstrates That LYSTEDA Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB
May 21, 2010
- Nexavar Data To Be Presented at 46th American Society of Clinical Oncology Annual Meeting
- Phase III study showed first-line maintenance use of MabThera doubles likelihood of people with follicular lymphoma living without their disease worsening
- Peregrine to Present Lung, Advanced Breast, and Brain Cancer Clinical Data at 2010 ASCO Annual Meeting
- ASCO presentation further demonstrates life-saving promise of chemo antidote
- Provectus Reports Further Positive Phase 2 Data on PV-10 for Metastatic Melanoma at ASCO
- ZIOPHARM to Present Further Palifosfamide PICASSO Phase II Results in Oral Session at ASCO
- Exelixis Reports Encouraging Interim Data From an Ongoing Phase 1b/2 Study of XL184 With or Without Erlotinib in Patients With Non-Small Lung Cancer to be Presented at ASCO
- Exelixis Reports Encouraging Interim Data from an Ongoing Adaptive Randomized Discontinuation Trial of XL184 in Patients With Solid Tumors to be Presented at ASCO
- Exelixis Reports Updated Phase 2 Data for XL184 in Patients With Recurrent Glioblastoma to Be Presented at ASCO
- Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncology (ASCO)
- Exelixis Reports Long-Term Phase 1 Results in a Cohort of Medullary Thyroid Cancer Patients Treated With XL184 to be Presented at ASCO
- Second Trial with ABRAXANE to Demonstrate Increased Survival in Patients with Advanced Pancreatic Cancer
- Two Studies Evaluated Full-Dose Chemotherapy Regimen and Concurrent Radiation in Treatment of Lung Cancer
- New Data On Invega Sustenna And Risperdal Consta For Schizophrenia To Be Presented At Major Psychiatry Meeting
- Anadys Announces Completed 12-Week Results From Phase II Combination Study of ANA598 With Interferon and Ribavirin
- Study Data Show INTUNIV (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
- Controlled Phase 2 Study of Ipilimumab Shows Clinical Activity in Advanced Non-Small Cell Lung Cancer
- Patients at high risk of recurrences of heart disease: Breakthrough in prevention
May 25, 2010
- Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010)
- Study Evaluated Vyvanse (lisdexamfetamine dimesylate) Capsules CII Efficacy and Safety in Adolescents with ADHD
May 26, 2010
- GTx Announces Top Line Results of Phase III Clinical Trial Evaluating Toremifene 20 mg for the Prevention of Prostate Cancer in Men with High Grade PIN
- Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism
- New Treatment Approach to Rare Cancer Results in Prolonged Survival
- DCE-MRI Study Abstract Selected by ASCO
- Study Identifies Promising Treatment for Aggressive Lymphoma
- Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
- Mayo Clinic Proceedings: Review of Pain Management Practices for Cirrhosis Patients
- Elixir Medical Corporation Announces Excellent Nine Month Safety and Efficacy Results from the EXCELLA II Randomized Clinical Trial
- Advanced Life Sciences Announces Restanza Shows Efficacy Against Malaria
